NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

4.330 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 14, 2026 Add to My Watchlist

Price and Volume

Volume	5
Open	4.330
Bid (Size)	4.250 (100)
Ask (Size)	4.650 (100)
Prev. Close	4.330
Today's Range	4.330 - 4.330
52wk Range	1.620 - 5.055
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

First Patients Treated via FDA-Cleared Transcranial Magnetic Stimulation, Plus FDA Grant on D-Cycloserine-Based Drug for Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

June 29, 2026

Via Get News

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

June 27, 2026

From New to The Street

Via ACCESS Newswire

Performance

YTD	+65.3%	+65.3%
1 Month	+6.1%	+6.1%
3 Month	+73.2%	+73.2%
6 Month	+103.3%	+103.3%
1 Year	+34.9%	+34.9%

More News

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

June 25, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

June 25, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression

June 22, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA

June 20, 2026

From New to The Street

Via ACCESS Newswire

NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.

June 05, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

June 04, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

These stocks are moving in today's pre-market session ↗

June 03, 2026

Via Chartmill

NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

June 03, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

What's going on in today's after hours session ↗

June 02, 2026

Via Chartmill

NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

June 02, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026

May 28, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

First Commercial Deployment of FDA-Cleared Transcranial Magnetic Stimulation (TMS) for Major Depressive Disorder and Other Neurological Conditions: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

May 28, 2026

Via Get News

NRx (NRXP) Q1 2026 Earnings Call Transcript ↗

May 27, 2026

Via The Motley Fool

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

May 27, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

Tuesday's session: top gainers and losers ↗

May 26, 2026

Via Chartmill

My Top 3 Biotech Stocks for May 2026 ↗

May 20, 2026

Via The Motley Fool

NRx Pharmaceuticals Q1 Earnings Call Highlights ↗

May 18, 2026

Via MarketBeat

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 18, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medicus Pharma

May 16, 2026

Via ACCESS Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update

May 14, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Clearance for Depression and Suicidality Trial

May 07, 2026

Via Investor Brand Network

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality

May 07, 2026

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Initiates First Commercial Manufacturing Order For Preservative-Free Ketamine

May 05, 2026

Via Investor Brand Network

Frequently Asked Questions

Is NRX Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, NRX Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does NRX Pharmaceuticals, Inc. - Common Stock trade on?

NRX Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock is NRXP on the Nasdaq Stock Market

What is the current price of NRX Pharmaceuticals, Inc. - Common Stock?

The current price of NRX Pharmaceuticals, Inc. - Common Stock is 4.330

When was NRX Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of NRX Pharmaceuticals, Inc. - Common Stock was at 07/14/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.